تقرير
Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)
| العنوان: | Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L) |
|---|---|
| المصدر: | MATCH Treatment Subprotocol Z1L: BVD-523FB (Ulixertinib) in Patients With Tumors With BRAF Fusions, or With Non-V600E, Non-V600K BRAF Mutations |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT06400225Test |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |